|Day Low/High||84.84 / 85.83|
|52 Wk Low/High||55.36 / 90.61|
In July, the RMPIA climbed 0.6%, bringing its year-to-date return to just over 21%.
Be sure your cannabis investments have the right CBD strategy, as the market for these products takes off.
This matters: Why the sudden 'weakness' across European debt markets?
I am neutral on this market, and only a cool off of the hottest stocks can justify a further advance.
By selling out of big losers prior to the quarter's close, portfolio managers can hide the stocks from clients, but some downtrodden shares could be ripe for bounces next week, so here's my list.
Amid May's market turbulence, the RMPIA was buoyed by the more than 4% rise from Medtronic.
A look at the charts and indicators of three big names in the sector .
Insider buying by corporate officers should be taken as optimistic visions of the future prospects of their companies and their stock prices.
These managed care stocks can withstand China, politics and a slowdown in the economy.
RMPIA outperformed once gain during April.
Aetna's additive effects on CVS's earnings might be front and center, but it isn't fully actualized just yet.
As CVS Health's stock continues to run, management's careful approach should be encouraging for beleaguered investors.
CVS is setting up an anticipated new stock trajectory for investors.
I've spotlighted three blue-chip companies with stock prices that are at ridiculously low valuations right now.
The free press that the progressive push for Medicare got on Tuesday morning is hurting the healthcare sector.
The health benefit giant's fundamentals are good, but there are more symptoms to consider for a proper examination.
It has become almost too onerous to own something that could be in Amazon's crosshairs.
The consumer is alive, well, and might benefit from a thaw with China and easy to get jobs. So would Boeing and Caterpillar.
Look at the entirety of your portfolio and make sure there are no earnings blow-ups coming from the companies that you own.
As I sit down to eat some lunch and gather my thoughts for the afternoon, here are some of the items I'll be reading up on: · Outgoing FDA chief Scott Gottlieb raises 'concern' over Walgreens Boosts Alliance, Inc. , and CVS Health Corp. selling CBD...
I have had to think long and hard about Lyft, the stock, not the ride-sharing company.
In fact, the de-emphasizing of cigarettes was blamed for declining same store sales.
The contagion in pharmacy stocks is spreading and secular trends aren't helping to find a solution anytime soon.